Cellular Intelligence is trying to build an AI model that can predict and eventually control how living cells behave, the same way AI models predict text or images, in hopes of making new medicines faster and cheaper to develop.
The company took a step toward that goal Monday, announcing that Moderna co-founder Robert “Bob” Langer and Turing Award-winning AI researcher Yann LeCun have joined its scientific advisory board, along with Jens Nielsen, chief executive of the Novo Nordisk Foundation’s BioInnovation Institute, and Fabian Theis, a computational biologist who directs the Computational Health Center at Helmholtz Munich. Langer is also joining the company’s board of directors as an observer.
.jpg?w=600)
